R84 Consortium · Remaining 84 · powered by PAICON

Was personalized medicine ever personal?

94.5%

of genome-wide association study participants are of European ancestry.

76%

of clinical trial participants from 2015 to 2019 were of primarily European descent.

China 51%

EGFR mutations in lung adenocarcinoma

vs about 20% in western populations.

India 2x

Triple-negative breast cancer

20 to 43% of breast cancers in India, vs about 15% in western populations.

Brazil 1 in 300

TP53 R337H founder variant

newborns in southern Brazil carry it, a variant almost absent elsewhere.

West Africa 30%

APOL1 kidney risk alleles

of West Africans carry two risk alleles, vs very few people of European ancestry.

AI did not create the gap. It made it visible.

Sources: GWAS Diversity Monitor via Cell Genomics (2024); clinical trial representation 2015 to 2019; PIONEER study, J Thorac Oncol 2014; TNBC in India, Clin Breast Cancer 2018; TP53 R337H newborn screening, JCO 2013 and Cancers 2021; APOL1 in West Africans, NEJM 2024.

The world's most diverse digital twin data, built to understand every patient.

Pathology

Whole-slide images, H&E and IHC

Omics

Exome, RNA and proteomics

Radiology

MRI, CT and PET

Clinical data

Diagnosis, treatment and response

Fused by multimodal AI · data stays on site

Drug-response simulationBefore patients carry the risk.

Virtual trial designTrials that represent who they treat.

Patient stratificationWho responds, and who is missed.

Population insightUnmet need across every region.

Principles every frontier can count on.

GDPR compliant by design

Consent, ethics and privacy come first.

Data sovereignty

Identifiers never leave your site.

Depth before breadth

Rich patient journeys over raw volume.

Lead the science

Pioneer innovation in undiscovered biology.

Personalized medicine

Based on ancestry and region-specific data.

Open for research

FAIR data, free for academic use.

Become a founding partner.

Who we would love to meet

Anyone who sees the gap

University hospitals, clinical centres, biobanks and research institutes. If your work touches patient care or patient data, we would like to hear from you.

What we can bring

A founding role, with early access and co-authorship.
PaiX Navigator for insight into your own patients.
Open science. FAIR data, freely accessible for research.
Support with funding. We look for ways to resource your participation together.

What you can expect

A scope that fits you, shaped around your patients and priorities.
Help with the paperwork, from ethics templates to data protection.
Your data stays on site, de-identified at source.
Step by step, at a pace that works for your team.

Every great partnership starts with a conversation. Tell us what you are working on, and we will show you what we could build together.

Let's talk ↓

Be a part of the change.

Whether you run a hospital, a biobank, a research group or a trial, there is a place for you in the R84 Consortium.

Hospitals & biobanksBring the patients you serve into a harmonised, research-ready dataset.

ResearchersShape the studies and ask the questions only diverse data can answer.

Industry & fundersPartner with us to build trials and products that work for everyone.

Join the R84 Consortium.